[{"NetIncomeLoss_2_Q2_USD":-2132000.0,"MarketableSecuritiesCurrent_0_Q2_USD":151272000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1212000.0,"InterestAndOtherIncome_2_Q2_USD":280000.0,"InterestAndOtherIncome_1_Q2_USD":136000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q2_USD":6771000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":32338000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":403000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":19111000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":115000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-109425000.0,"Depreciation_2_Q2_USD":1479000.0,"ConstructionInProgressGross_0_Q2_USD":3729000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":407000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":485000.0,"AssetsCurrent_0_Q2_USD":293081000.0,"AccruedVacationCurrent_0_Q2_USD":5381000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2434000.0,"ShareBasedCompensation_2_Q2_USD":8784000.0,"AccruedSalesCommissionCurrent_0_Q2_USD":5965000.0,"Assets_0_Q2_USD":348936000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":2705000.0,"CommonStockSharesIssued_0_Q2_shares":40191609.0,"OperatingLeaseLiability_0_Q2_USD":2434000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":14450000.0,"Land_0_Q2_USD":572000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":486000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":34184000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":40061000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":80343000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":122193000.0,"FurnitureAndFixturesGross_0_Q2_USD":3360000.0,"UndistributedEarningsLossAvailableToCommonShareholdersBasic_2_Q2_USD":-2132000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-154000.0,"Liabilities_0_Q2_USD":75104000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":9601000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2602000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":2268000.0,"EarningsPerShareBasic_2_Q2_USD":-0.06,"EarningsPerShareBasic_1_Q2_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":1216000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":38746410.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":38808980.0,"ProceedsFromStockPlans_2_Q2_USD":2098000.0,"AccountsReceivableNetCurrent_0_Q2_USD":32526000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":126000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":63000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-852000.0,"CommonStockValue_0_Q2_USD":39000.0,"PaymentsToAcquireOtherInvestments_2_Q2_USD":2175000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-111680000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-1788000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":642702000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1941000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":73783000.0,"OtherAssetsNoncurrent_0_Q2_USD":11734000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":304000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":608000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-85000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2192000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-2286000.0,"MachineryAndEquipmentGross_0_Q2_USD":18893000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4800000.0,"DeferredRevenueNoncurrent_0_Q2_USD":3644000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":2485000.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":140825000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-141000.0,"UndistributedEarningsLossAvailableToCommonShareholdersBasic_1_Q2_USD":-56000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":168000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-2006000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":7000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":3817000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-467000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":10690000.0,"OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities_2_Q2_USD":0.0,"LeaseholdImprovementsGross_0_Q2_USD":681000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":38746410.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":38808980.0,"CostOfRevenue_2_Q2_USD":26484000.0,"CostOfRevenue_1_Q2_USD":13920000.0,"GainLossOnDispositionOfAssets_2_Q2_USD":138000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":494000.0,"LiabilitiesCurrent_0_Q2_USD":48085000.0,"DeferredRevenueCurrent_0_Q2_USD":2078000.0,"AccountsPayableCurrent_0_Q2_USD":13669000.0,"NonoperatingIncomeExpense_2_Q2_USD":-631000.0,"NetIncomeLoss_1_Q2_USD":-56000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":28123000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-69000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":10549000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":15998000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":2430000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":21532000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0254,"GrossProfit_2_Q2_USD":98229000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2064000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2994000.0,"InterestExpense_1_Q2_USD":412000.0,"InterestExpense_2_Q2_USD":911000.0,"NonoperatingIncomeExpense_1_Q2_USD":-276000.0,"GrossProfit_1_Q2_USD":50249000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1208000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":851000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1205000.0,"OperatingLeaseCost_2_Q2_USD":252000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":18266000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":1515000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q2_USD":10158000.0,"InventoryNet_0_Q2_USD":32506000.0,"OperatingIncomeLoss_1_Q2_USD":283000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":348936000.0,"OperatingIncomeLoss_2_Q2_USD":-1375000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":64169000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":124713000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":108000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":483000.0,"BuildingsAndImprovementsGross_0_Q2_USD":22420000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":18653000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":49655000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":608000.0,"CommonStockSharesOutstanding_0_Q2_shares":40191609.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":7314000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-369024000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-625000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":1658000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1992000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":493000.0,"StockholdersEquity_0_Q2_USD":273832000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.06,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":2238000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":913000.0,"OperatingExpenses_1_Q2_USD":49966000.0,"OperatingExpenses_2_Q2_USD":99604000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2659000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":251000.0,"Ticker":"CSII","CIK":"1180145","name":"CARDIOVASCULAR SYSTEMS INC","OfficialName":"Cardiovascular Systems Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"887461899.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20210204"}]